Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology
Bryony J. Telford, Sanaz Yahyanejad, Thijs de Gunst, et al.
Oncotarget (2021) Vol. 12, Iss. 5, pp. 422-439
Open Access | Times Cited: 24

Showing 24 citing articles:

MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies
Tae‐Wan Kim, Carlo M. Croce
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1314-1321
Open Access | Times Cited: 208
Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis
Weinan Guo, Zhenjie Wu, Jianru Chen, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004381-e004381
Open Access | Times Cited: 81
MicroRNAs in cancer metastasis: biological and therapeutic implications
Marie C. Sell, Charmaine A. Ramlogan‐Steel, Jason C. Steel, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Open Access | Times Cited: 26
MicroRNAs in extracellular vesicles: A potential role in cancer progression
Deepak Parashar, Tanmoy Mukherjee, Saurabh Gupta, et al.
Cellular Signalling (2024) Vol. 121, pp. 111263-111263
Closed Access | Times Cited: 10
Regulation of Angiogenesis by Non-Coding RNAs in Cancer
Zhiyue Su, Wenshu Li, Zhe Lei, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 60-60
Open Access | Times Cited: 7
Nanotechnology-based delivery systems to overcome drug resistance in cancer
Harsh Patel, Jiaxin Li, Letao Bo, et al.
Medical Review (2024) Vol. 4, Iss. 1, pp. 5-30
Open Access | Times Cited: 6
Clinical progress of nanomedicine-based RNA therapies
Siyoung A. Lim, Alysia Cox, Madelynn Tung, et al.
Bioactive Materials (2021) Vol. 12, pp. 203-213
Open Access | Times Cited: 37
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities
Khadijeh Mahboobnia, Dianne J. Beveridge, George C. Yeoh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9393-9393
Open Access | Times Cited: 5
In vivo gene immunotherapy for cancer
David Mai, Carl H. June, Neil C. Sheppard
Science Translational Medicine (2022) Vol. 14, Iss. 670
Closed Access | Times Cited: 19
RNA-based Therapeutics: Past, Present and Future Prospects, Challenges in Cancer Treatment
Anjana Goel, Amisha Rastogi, M. Jain, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2125-2137
Closed Access | Times Cited: 4
The Multifaceted Roles of MicroRNA-181 in Stem Cell Differentiation and Cancer Stem Cell Plasticity
Chun Yang, Rui Wang, Pierre Hardy
Cells (2025) Vol. 14, Iss. 2, pp. 132-132
Open Access
The Relevance of the Accurate Annotation of Micro and Long Non-Coding RNA Interactions for the Development of Therapies
Simona Panni
Genes (2025) Vol. 16, Iss. 3, pp. 262-262
Open Access
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials
Roberto Piergentili, Stefano Sechi
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 471-471
Open Access
The Role of MiR-181 Family Members in Endothelial Cell Dysfunction and Tumor Angiogenesis
Chun Yang, Victor Passos Gibson, Pierre Hardy
Cells (2022) Vol. 11, Iss. 10, pp. 1670-1670
Open Access | Times Cited: 16
The potential of microRNAs in cancer diagnostic and therapeutic strategies: a narrative review
Minh Trong Quang, Minh Nam Nguyen
The Journal of Basic and Applied Zoology (2024) Vol. 85, Iss. 1
Open Access | Times Cited: 3
Deciphering the Multifaceted Role of microRNAs in Hepatocellular Carcinoma: Integrating Literature Review and Bioinformatics Analysis for Therapeutic Insights
Fereshteh Rahdan, Alihossein Saberi, Neda Saraygord‐Afshari, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e39489-e39489
Open Access | Times Cited: 3
Transcriptome-wide analysis reveals insight into tumor suppressor functions of 1B3, a novel synthetic miR-193a-3p mimic
Marion T.J. van den Bosch, Sanaz Yahyanejad, Mir Farshid Alemdehy, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 23, pp. 1161-1171
Open Access | Times Cited: 16
Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment
Atqiya Fariha, Ithmam Hami, Mahafujul Islam Quadery Tonmoy, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e11081-e11081
Open Access | Times Cited: 12
INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death
Chantal L. Duurland, Thijs de Gunst, Harm C. den Boer, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 470-485
Open Access | Times Cited: 1
Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection
Mark S. Gibson, Cláudia Filipa de Noronha Estima, Margarida Gama‐Carvalho
Genes (2022) Vol. 13, Iss. 2, pp. 273-273
Open Access | Times Cited: 7
Epigenetic inhibitors and their role in cancer therapy
Nouha Abdelaziz, Lubna Therachiyil, Hana Q. Sadida, et al.
International review of cell and molecular biology (2023), pp. 211-251
Closed Access | Times Cited: 3
miRNA-Based Therapeutic Strategy and Its Application in Breast Cancer
Sema Mısır, Serap Özer Yaman, Osman Akidan, et al.
IntechOpen eBooks (2024)
Open Access
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications
Roman Beňačka, Daniela Szabóová, Zuzana Guľašová, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 127-127
Open Access
The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis
Marion T.J. van den Bosch, Bryony J. Telford, Sanaz Yahyanejad, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access
Early detection of breast cancer by organ-specific and circulatory liquid biopsies
Susana Isabel Schouten Patuleia
(2022)
Open Access
Page 1

Scroll to top